Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes

OBJECTIVE: To investigate whether the dipeptidyl peptidase-4 inhibitor vildagliptin improves endothelium-dependent vasodilatation in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Sixteen subjects with type 2 diabetes (age 59.8 ± 6.8 years, BMI 29.1 ± 4.8 kg/m(2), HbA(1c) 6.97 ± 0.61) o...

Descripción completa

Detalles Bibliográficos
Autores principales: van Poppel, Pleun C.M., Netea, Mihai G., Smits, Paul, Tack, Cees J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161271/
https://www.ncbi.nlm.nih.gov/pubmed/21788633
http://dx.doi.org/10.2337/dc10-2421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161271/
https://www.ncbi.nlm.nih.gov/pubmed/21788633
http://dx.doi.org/10.2337/dc10-2421

Ejemplares similares